You appear to be using an older version of Internet Explorer. We suggest you upgrade your browser for the best viewing experience. Upgrade to a Modern Browser

J A Kemp Webinar: Patenting Antibodies at the EPO

17 May 2018

This webinar is now available on-demand. Click here to access the recording.

Antibody therapeutics is a rapidly developing field, with many antibody-based therapies now on the market and in the clinic. Patenting of antibodies, particularly for known targets, is proving increasingly difficult. The day-to day practice at the European Patent Office is constantly evolving, moving forward much faster than the Case Law. This webinar makes use of the significant experience of J A Kemp’s attorneys in prosecuting antibody cases at the European Patent Office, as well as discussions with EPO examiners, highlighting recent trends in examination and strategies for addressing objections.

Topics include:

  • When broad antibody claims can be obtained
  • How to approach inventive step when the target is known
  • What data to provide to support inventive step
  • Functional/epitope claims
  • Other routes to patentability 

Can We Help You?

keyboard_arrow_up